Unravelling the familial tendency to aneurysmal disease: Popliteal aneurysm, hypertension and fibrillin genotype  by MacSweeney, S.T.R. et al.
Eur J Vasc Endovasc Surg 12, 162-166 (1996) 
Unravelling the Familial Tendency to Aneurysmal Disease: 
Popliteal Aneurysm, Hypertension and Fibrillin Genotype* 
S. T. R. MacSweeney  1, C. Sk idmore  1, R. J. Turner 2, M. Sian 1 , L. Brown 1, A. M. Henney 3, 
R. M. Greenhalgh ~ and J. T. Powell  ~'2t 
Departments of 1Surgery and 2Biochemistry, Charing Cross & Westminster Medical School, Fulham Palace Road, 
London W6 8RF and 3Cardiovascular Genetics, The Rayne Institute, 5 University Street, London WCIE 9]J, U.K. 
Purpose: To screen patients with abdominal aortic aneurysm for popliteal aneurysm and investigate cardiovascular nd 
genetic risk factors associated with aneurysmal disease at more than one site (generalised aneurysmal disease). 
Subjects, design and setting: All patients referred to the Regional Vascular Surgical Service at Charing Cross Hospital 
with unruptured abdominal aortic aneurysm between 1989 and 1993 were screened for popliteal aneurysms, using 
ultrasonography. 
Main outcome measures: Palpation of a popliteal aneurysm or ultrasonographic detection of popliteaI dilatation, where 
the ratio maximum popliteal fossa diameter/suprageniculate popliteaI diameter was ,- 1.5, in relation to cardiovascular nd 
genetic risk factors. 
Results: Clinical examination detected popliteal aneurysms in only 11/232 patients (5%), but ultrasonography 
demonstrated the presence of popliteal aneurysm in a further 13 patients, 24/232 in total (10%). Multivariate regression 
identified four independent factors associated with popliteal dilatation disease : age (p = 0.046), height (p = 0.006), systolic 
hypertension (p = 0.037) and triglyceride concentration (p = 0.009). Generalised aneurysmal disease and systolic blood 
pressure were associated with polymorphic variation in the fibrillin-1 gene, but not with variations in the apolipoprotein 
B and type III collagen genes. 
Conclusions: Few patients with abdominal aortic aneurysm (10%) also have popliteal aneurysms: the risk of popliteaI 
dilatation increases with age, height, systolic blood pressure, triglyceride concentration and fibrillin genotype.The strong 
interaction between fibrillin genotype and blood pressure may contribute to the familial tendency to aortic aneurysm. 
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Introduction 
Smoking is an important risk factor for the develop- 
ment and rupture of abdominal aortic aneurysms 
(AAA). ~'2 Smoking also is associated with aortic 
atherosclerosis. 3 These associations provide the back- 
ground for the continuing debate as to whether 
abdominal aortic aneurysm is caused by athero- 
sclerosis. 4'5 Alternatively, the strong familial clustering 
of abdominal aortic aneurysms may indicate a genetic 
cause for AAA. 5-8 Fusiform atherosclerotic aneurysms 
may also occur in the thoracic aorta, femoral and 
popliteal arteries, of which popliteal aneurysms may 
be the most common. Sometimes, a patient may have 
multiple aneurysms. Observational studies have dem- 
onstrated that the risk of thromboembolic complica- 
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tions from popliteal aneurysm is increased in patients 
with aneurysms at other sites. 9'~° With this knowledge 
should we screen patients with AAA for popliteal 
aneurysm? In this study we have attempted toanswer 
this question and investigate the hypothesis that the 
risk factors for aneurysmal disease might be most 
clearly recognised in those with aneurysms at more 
than one site (generalised aneurysmal disease). 
Patients and methods 
The 232 patients included all those who presented to 
the Regional Vascular Surgical Service with an unrup- 
tured AAA between January 1989 and December 1993. 
These patients consisted of 193 men and 39 women, 
median age 71 years (range 52-93 years) of whom 10 
(4.3%) were diabetic. Medical, smoking and exercise 
histories were recorded. The patients underwent 
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Table 1. Characteristics of the patients and arterial diameters 
AAA and 
popliteal 
AAA only aneurysm 
(n=208) (n=24) 
Men (%) 171 (82) 22 (92) 
Age (years) 71 (5349) 73 (52-93) 
Height (cm) 171 (141-190) 175 (152-190) 
Weight (kg) 73.2 (41.9-110) 77.5 (45.3-107) 
Smoking history (pack years) 38 (0-300) 37 (0-70) 
Diabetes 10 (5) 0 (0) 
Systolic BP (mmHg) 155 (110-210) 165 (120-210) 
Diastolic BP (mmHg) 90 (60-125) 90 (66-120) 
ABPI (worst leg) 0.88 (0.15-1.1) 0.81 (0.44-1.1) 
Cholesterol (mnol/1) 6.2 (3.4-13.5) 6.1 (4.2-8.2) 
Triglycerides (mmol/1) 1.53 (0.51-7.0) 1.70 (0.81-11.2) 
Fibrinogen (g/l) 4.4 (1.75-8.6) 4.45 (2.8~.25) 
AAA diameter (cm) 5.0 (3.1-11.7) 5.1 (3.1-12.0) 
Suprageniculate popliteal 0.78 (0.5-1.4) 0.78 (0.59-1.6) 
diameter (cm) 
Maximum popliteal rtery 0.85 (0.5-1.82) 1.62 (1.14.6) 
diameter (cm) 
Results for continuous variables are given as median (ranges). 
clinical examination which included palpation of the 
popliteal fossa. Ultrasonography was used to deter- 
mine the maximum anterior-posterior diameter of the 
aortic aneurysm and in longitudinal view the external 
diameters of the suprageniculate popliteal artery, the 
popliteal artery in the popliteal fossa and the infra- 
geniculate popliteal artery in both legs. The popliteal 
arteries were imaged with an ATL-HDI instrument 
using a 5 MHz linear probe. Systolic and diastolic 
blood pressures and ankle/brachial systolic pressure 
indices also were measured. A fasting blood sample 
was obtained for the analysis of plasma cholesterol 
and triglycerides, fibrinogen, the smoking marker 
carboxyhaemoglobin and the preparation of genomic 
11 12  DNA as previously described. ' The genomic DNA 
was analysed for polymorphic variation in the apoli- 
poprotein B, type III collagen and fibrillin genes as 
previously described. ~z-14 
Statistical analysis 
Multivariate regression analysis was performed using 
the Statview package for Macintosh computers. Dis- 
tributions of genotypes were assessed using Chi- 
squared tests. 
Resu l ts  
The demographic data for the patients is given in 
Table 1. The diameter of the aortic aneurysm ranged 
from 3.1-12.0 cm. 
Popliteal aneurysms were detected on clinical 
examination i 11 patients, the aneurysm was bilateral 
in five patients : the median aneurysm diameter was 
2.0cm (range 1.6-4.6 cm) and the ratio maximum 
diameter of the artery in the popliteal fossa/suprage- 
niculate popliteal artery diameter anged from 1.5 to 
5.2. This ratio exceeded 1.5 in a total of 24 patients, 
including the 11 patients in whom the popliteal 
aneurysms were revealed on clinical examination. In 
these 24 patients with dilated arteries in the popliteal 
fossa, the dilatation was bilateral in 12 patients and the 
median diameter of the dilated segment was 1.6cm 
(range 1.1-4.6 cm). Thrombus was observed in the 
dilated popliteal segment in 14/24 patients, including 
all the patients with aneurysms a2.0 cm in diameter. 
In all 24 patients in whom the maximum popliteal/ 
suprageniculate diameter exceeded 1.5, the maximum 
popliteal/infrageniculate popliteal diameter ratio also 
was greater than 1.5. The median popliteal diameter 
ratio (popliteal fossa diameter/suprageniculate diam- 
eter) in the remaining 208 patients was 1.03 (range 
0.82-1.45), 95 patients having a ratio of _< 1.0. The 
frequency distribution of the popliteal diameter atio 
in all 232 patients is shown in Fig. 1. 
Backward, stepwise, multivariate regression analy- 
sis identified four factors to be independently asso- 
ciated with the popliteal diameter atio : age, height, 
systolic blood pressure and triglyceride concentration 
(Table 2). Sex, weight, pack-years of smoking history, 
diabetes, diameter of the AAA, intermittent claudica- 
tion, ABPI, exercise history, diastolic blood pressure, 
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Fig. 1. Popliteal diameter ratio in 232 patients with AAA. The ratio 
was calculated from maximum diameter of the artery in the 
popliteal fossa and the suprageniculate popliteal artery diameter. 
The highest value, from either ight or left leg, is plotted. Twenty- 
four patients had a ratio of _>1.5, indicative of popliteal 
aneurysm. 
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Table 2. Predictors of popliteal artery dilatation 
Coefficient S.E. t p 
Age 0.0070 0.0031 2.01 0.046 
Height 0.0046 0.0017 2.76 0.006 
Systolic BP 0.0016 0.007 2.14 0.037 
Triglyceride 0.062 0.023 2.64 0.009 
F-value 359. 
p<0.0001. 
suprageniculate popliteal diameter, plasma choles- 
terol and fibrinogen concentrations were not asso- 
ciated with the popliteal diameter ratio. Of the 
patients with popliteal aneurysm the median ABPI 
was not different in the 14 patients with evident 
thrombus in the aneurysm, compared with the 10 
patients without thrombus. 
Genomic DNA from the patients was examined for 
polymorphic variation in the apolipoprotein B, type III 
collagen and fibrillin-1 genes. The distribution of 
diallelic polymorphisms in the apolipoprotein B (Xbal) 
and type IIl collagen (531 Ala/Thr) genes was not 
associated with popliteal dilatation (Table 3). The 
fibrillin-1 genotyping was performed on the basis of a 
4-allele (TAAAA)n repeat, 14 which provided three 
common genotypes in patients with AAA. Genotyp- 
ing was performed on the 24 patients with AAA and 
popliteal aneurysm and on 128 patients with AAA 
alone. Of these the most common genotype, found in 
over half the patients with AAA only was 2-2 
(frequency 0.55), with the 2-3 genotype (frequency 
Table 3. Distributions of apolipoprotein B and type III collagen 
genotypes in AAA patients 
AAA only AAA and 
popliteal 
aneurysm 
Apo B (XbaI) XIX1 38 (31.4%) 7 (29.2%) 
XIX2 63 (52.1%) 14 (58.3%) 
X2X2 20 (16.5.%) 3 (12.5%) 
(n=121) T (n=24) 
Collagen III (531) A/A 49 (39.5%) 7 (29.2%) 
A/T 58 (46.8%) 10 (41.7%) 
T/T 17 (13.7%) 7 (29.2%) 
(n=124)* (n=24) 
The distribution ofboth the apolipoprotein B and type III collagen 
genotypes were in accord with Hardy Weinberg equilibrium. For 
apolipoprotein B the frequency ofthe X2 allele was 0.42, very similar 
to the frequency of this allele (0.43) in patients with peripheral 
arterial disease.[ 12] 
For type III collagen the frequency of threonine (531) was 0.37, 
similar to the frequency of this allele (0.35) in patients with 
peripheral rterial disease, but higher than was reported previously 
for patients with abdominal ortic aneurysm (0.253).[ ~3] 
+ m Genotyp" g was not performed on all of the patients with AAA 
only. 
Table 4a. Distribution of principal fibrillin genotypes in patients 
AAA only AAA and 
(n=128) popliteal 
aneurysm 
(n=24) 
2-2 70 (54.7%) 13 (54.2%) 
2-3 21 (16.4%) 9 (37.5%) 
2,-4 25 (19.5%) 0 (0%) 
Others 12 (9.4%) 2 (8.3%) 
Chi-squared=9.27. 
p=0.026 
0.16) and the 2-4 genotype (frequency 0.20) also being 
common. In these patients 76/128 were not taking 
antihypertensive medications. In these 76 patients 
there was a strong association between fibrillin geno- 
type and systolic blood pressure, but not with any of 
the other variables listed in Table 1. The distribution of 
patients, not taking any anti-hypertensive medication, 
about the median systolic pressure according to the 
three most common genotypes (n = 71) is shown in 
Table 4b. Patients of 2-3 genotype had the highest 
systolic pressures and patients of 2-4 genotype, nine 
patients (38%) were of 2-3 genotype, 13 (59%) of 2-2 
genotype, one patient had a 3-3 genotype and one 
patient a 1-3 genotype (Table 4a). This distribution of 
genotypes in patients with AAA and popliteal dilata- 
tion is different from the distribution in patients with 
AAA only, chi-squared p = 0.03. The genotype asso- 
ciated with systolic hypertension (2-3) appeared to be 
more frequent in the patients with AAA and popliteal 
dilatation. 
Discussion 
All popliteal aneurysms with a maximum diameter of 
___ 2.0cm were detected by dinical examination. In a 
normal popliteal artery the change in diameter as the 
artery traverses the knee joint is minimal and it may 
taper to a smaller infrageniculate diameter. The limits 
of agreement with which these diameters may be 
measured by ultrasonography is similar to that for the 
Table 4b. Distribution of principal fibrillin genotypes according to 
median systolic pressure, 160mmHg 
Fibrillin genotype 2-4 2-2 2-3 
Below median systolic BP 15 20 1 
Above median systolic BP 3 21 11 
Chi-squared=16.32 
p=0.002 
Only patients not taking anti-hypertensive medication are included 
in this analysis. 
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common femoral artery, _+ lmm. 15 Therefore for a 
suprageniculate popliteal artery of median diameter 
(0.78cm) the true diameter lies in the range 
0.68-0.88cm, the ratio of these two end of range 
diameters being 1.3. A ratio of maximum popliteal 
fossa diameter/suprageniculate diameter of _>1.5, 
therefore is likely to represent a true dilatation of the 
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Fig. 2. Systolic blood pressure and fibrillin genotype inpatients with 
AAA. Information isgiven for patients, not taking anti-hypertensive 
medication., of the three principal fibrillin-1 genotypes. The bars 
show the median systolic pressures for each genotype. Differences 
between groups have been assessed by Mann Whitney U-test. The 
systolic pressure is highest for those of 2-3 genotype. 
artery in the popliteal fossa, even for the smallest 
diameter vessels. Further confirmation of a localised 
dilatation can be obtained by verifying that the ratio 
maximum popliteal fossa diameter/infrageniculate 
"popliteal diameter also was __. 1.5. We have considered 
that a popliteal diameter atio of _> 1.5 indicates a true 
dilatation of this artery in the popliteal fossa and using 
this criterion 24/232 (10.3%) patients with AAA also 
had popliteal aneurysms. 
Claudication was not a useful guide to the presence 
of popliteal aneurysm. Eighty-nine of the 232 patients 
had intermittent claudication, 11/24 (46%) of those 
with popliteal aneurysm and 78/208 (38%) of those 
with AAA only. Similarly ABPI was not a useful 
indicator of popliteal aneurysm. However three risk 
factors for peripheral atherosclerosis, age, systolic 
blood pressure and triglycerides were associated with 
popliteal aneurysm in AAA patients. ~6'17 Similarly 
height, together with age and systolic blood pressure, 
are risk factors for AAA. 2'4"~s No distinctive risk factor 
was associated with generalised aneurysmal disease, 
although the strongest predictors, height and tri- 
glycerides were unexpected. In population studies 
cholesterol has been the important lipid risk factor for 
both peripheral atherosclerosis and AAA. 2"16 
Apolipoprotein B acts as a marker for triglyceride 
rich lipoproteins and the Xbal polymorphism in this 
I "Environmental Factors" 1 including: Ageing Smoking i i/I 1 "Haemodynamic Factors . . . .  Genetic Factors" including: including: Systolic Hypertension q Fibrillin-1 genotype 
I 1 properties of the arterial wall 
I Aneurysmal ~__  
Dilatation 
Fig. 3. Schematic diagram suggesting interelationship of genetic and environmental f ctors in the development of systolic hypertension a d 
aneurysmal dilatation. 
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gene has been associated with triglyceride concentra- 
tions. 19 However, the distribution of genotypes 
amongst AAA patients was similar in those with AAA 
only and those with AAA and popliteal aneurysm. 
Fibrillin-1, the Marfan gene, encodes a protein found 
in the myofibrils of the aorta and other tissues. 14 The 
polymorphic (TAAAA)n repeat in this gene is asso- 
ciated with blood pressure in healthy middle aged 
men, those of 2-3 genotype having the highest pulse 
pressure. 2°In AAA patients this same polymorphism 
in the fibrillin-1 gene also was strongly associated 
with systolic blood pressure, AAA patients of 2-3 
genotype having the highest pressures (Fig. 2). This 
association may explain the over representation f the 
2-3 genotype amongst patients with AAA and popli- 
teal aneurysm (Fig. 3). 
In summary, few patients with AAA (10%) have 
asymptomatic popliteal aneurysms. The largest of 
these aneurysms, probably those with the greatest risk 
of complications, can be detected by clinical examina- 
tion. A programme to screen AAA patients for 
popliteal aneurysms, using ultrasonograph3~ would 
be of limited value. The principal risk factors for the 
development of popliteal aneurysm in AAA patients 
are age, height, systolic blood pressure and triglycer- 
ide concentration. The strong interaction between 
blood pressure, fibrillin genotype and popliteal aneu- 
rysm indicates that the familial tendency to AAA may 
arise from genetic variation in aortic proteins which 
influence both hypertension and arterial wall struc- 
ture in the ageing patients. 
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